Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 20, 2018.
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-3812-01
- Dosage Form
- Injection
- Presentation
- Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 125 mg/50 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Multiple Dose Vial Novaplus (NDC 0409-3812-01)
- Initial Posting
- Feb 20, 2018